Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03154580 · ClinicalTrials.gov registry record · Phase 1
Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users
A Phase 1 study of Marijuana Abuse, sponsored by Wayne State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT03154580 is a Phase 1 study of Marijuana Abuse that has completed, run by Wayne State University. The registered enrollment target is 21 participants, below the 93-participant average among 4 other Marijuana Abuse trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03154580, a Phase 1 study of Marijuana Abuse, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed study is to examine the relationship between marijuana reminders, or "cues", craving for marijuana, and marijuana use. The principal investigator is also assessing whether N-acetylcysteine, can reduce marijuana craving or use.
Conditions Studied
Interventions
- DRUG N-acetyl cysteine
Study Locations (1)
Michigan
- Tolan Park Medical Building - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2023-06-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03154580
The ClinicalTrials.gov registry entry for NCT03154580 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 93-participant average among 4 other Marijuana Abuse trials with a reported enrollment target (77% lower). The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Marijuana Abuse appearing as the primary indexed condition, and to 1 intervention - of which N-acetyl cysteine is the first listed.
NCT03154580 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03154580 about?
NCT03154580 is a clinical study titled "Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users". The purpose of the proposed study is to examine the relationship between marijuana reminders, or "cues", craving for marijuana, and marijuana use. The principal investigator is also assessing whether N-acetylcysteine, can reduce marijuana craving or use.
What is the current status of trial NCT03154580?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2017-05-01. Estimated completion is 2023-06-27.
What conditions does trial NCT03154580 study?
This clinical trial studies the following conditions: Marijuana Abuse.
What interventions are being tested in trial NCT03154580?
The interventions under investigation include: N-acetyl cysteine (DRUG).
Who is sponsoring clinical trial NCT03154580?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03154580 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Marijuana Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.